Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation

详细信息    查看全文

• 作者：Suprit D. Saoji ; Sandip C. Atram ; Pradip W. Dhore ; Priya S. Deole…
• 关键词：film ; forming polymers ; hydrophilic polymers ; permeation enhancers ; transdermal films
• 刊名：AAPS PharmSciTech
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：16
• 期：6
• 页码：1344-1356
• 全文大小：3,538 KB
• 参考文献：1.Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3(2):115-4.CrossRef PubMed
  2.Ruby PK, Pathak SM, Aggarwal D. Critical attributes of transdermal drug delivery system (TDDS)—a generic product development review. Drug Dev Ind Pharm. 2014;40(11):1421-.CrossRef PubMed
  3.Thomas BJ, Finnin BC. The transdermal revolution. Drug Discov Today. 2004;9(16):697-03.CrossRef PubMed
  4.Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010;1(1):109-1.PubMedCentral CrossRef PubMed
  5.Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261-.PubMedCentral CrossRef PubMed
  6.Zadymova NM. Colloidochemical aspects of transdermal drug delivery (review). Colloid J. 2013;75(5):491-03.CrossRef
  7.Vavrova K, Zbytovska J, Hrabalek A. Amphiphilic transdermal permeation enhancers: structure-activity relationships. Curr Med Chem. 2005;12(19):2273-1.CrossRef PubMed
  8.Williams AC, Barry BW. Essential oils as novel human skin penetration enhancers. Int J Pharm. 1989;57(2):R7-.CrossRef
  9.Patil U, Saraogi R. Natural products as potential drug permeation enhancer in transdermal drug delivery system. Arch Dermatol Res. 2014;306(5):419-6.CrossRef PubMed
  10.Karande P, Jain A, Ergun K, Kispersky V, Mitragotri S. Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci U S A. 2005;102(13):4688-3.PubMedCentral CrossRef PubMed
  11.Parikh D, Ghosh T. Feasibility of transdermal delivery of fluoxetine. AAPS PharmSciTech. 2005;6(2):E144-.PubMedCentral CrossRef PubMed
  12.Williams AC, Barry BW. Terpenes and the lipid protein partitioning theory of skin penetration enhancement. Pharm Res. 1991;8(1):17-4.CrossRef PubMed
  13.Gao S, Singh J. In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes. J Control Release. 1998;51(2-):193-.CrossRef PubMed
  14.Herman A, Herman AP. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review. J Pharm Pharmacol. 2015;67(4):473-5.CrossRef PubMed
  15.Zhao KD, Singh J. In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J Control Release. 1999;62(3):359-6.CrossRef PubMed
  16.Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air. J Pharm Sci. 1983;72(10):1189-1.CrossRef PubMed
  17.Kusum Devi V, Saisivam S, Maria GR, Deepti PU. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev Ind Pharm. 2003;29(5):495-03.CrossRef PubMed
  18.Mutalik S, Udupa N. Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations. J Pharm Sci. 2004;93(6):1577-4.CrossRef PubMed
  19.Chandak AR, Verma PRP. Development and evaluation of HPMC based matrices for transdermal patches of tramadol. Clin Res Regul Aff. 2008;25(1):13-0.CrossRef
  20.Kshirsagar SJ, Bhalekar MR, Mohapatra SK. Development and evaluation of carvedilol-loaded transdermal drug delivery system: in-vitro and in-vivo characterization study. Drug Dev Ind Pharm. 2012;38(12):1530-.CrossRef PubMed
  21.Madan JR, Argade NS, Dua K. Formulation and evaluation of transdermal patches of donepezil. Recent pat drug delivery formulation. 2014.
  22.Hayton WL, Chen T. Correction of perfusate concentration for sample removal. J Pharm Sci. 1982;71(7):820-.CrossRef PubMed
  23.Barry BW. Mode of action of penetration enhancers in human skin. J Control Release. 1987;6(1):85-7.CrossRef
  24.Riviere A. Dose finding study of granisetron in patients receiving high-dose cisplatin chemotherapy. The Granisetron Study Group. Br J Cancer. 1994;69(5):967-1.PubMedCentral CrossRef PubMed
  25.Yener G, Uuml LG, Uuml, Uuml, Ner M, et al. Design of meloxicam and lornoxicam transdermal patches: preparation, physical characterization, ex vivo and in vivo studies. Chem Pharm Bull. 2010;58(11):1466-3.CrossRef PubMed
  26.Khana R, Agarwal SP, Ahuja A. Preparation and evaluation of muco-adhesive buccal films of clotrimazole for oral candida infections. Indian J Pharm Sci. 1997;59(6):299-05.
  27.Pinguet F, Bressolle F, Martel P, Salabert D, Astre C. High-performance liquid chromatographic determination of granisetron in human plasma. J Chromatogr B Biomed Appl. 1996;675(1):99-05.CrossRef PubMed
  28.Aggarwal G, Dhawan S, Hari Kumar SL. Formulation, in vitro and in vivo evaluation of transdermal patches containing risperidone. Drug Dev Ind Pharm. 2013;39(1):39-0.CrossRef PubMed
  29.Greenspan L. Humidity fixed points of binary saturated aqueous solutions. J Res Nat Bur Stand Sect A. 1977;81A(1):89-6.CrossRef
  30.Suwanpi
• 作者单位：Suprit D. Saoji (1)
  Sandip C. Atram (2)
  Pradip W. Dhore (1)
  Priya S. Deole (3)
  Nishikant A. Raut (1)
  Vivek S. Dave (4)
  
  1. Department of Pharmaceutical Sciences, R. T. M. Nagpur University, Nagpur, India
  2. Vidyabharati College of Pharmacy, Amravati, India
  3. G. S. Tompe College, Chandurbazar, Amravati, India
  4. St. John Fisher College, Wegmans School of Pharmacy, 3690 East Avenue, Rochester, New York, 14618, USA
  
• 刊物主题：Pharmacology/Toxicology; Biotechnology; Biochemistry, general; Pharmacy;
• 出版者：Springer US
• ISSN：1530-9932

文摘

The influence of formulation variables, i.e., a hydrophilic polymer (Methocel? E15) and a film-forming polymer (Eudragit? RL 100 and Eudragit? RS 100), on the physicochemical and functional properties of a transdermal film formulation was assessed. Several terpenes were initially evaluated for their drug permeation enhancement effects on the transdermal film formulations. d-Limonene was found to be the most efficient permeation enhancer among the tested terpenes. Transdermal film formulations containing granisetron (GRN) as a model drug, d-limonene as a permeation enhancer, and different ratios of a hydrophilic polymer (Methocel? E15) and a film-forming polymer (Eudragit? RL 100 or Eudragit? RS 100) were prepared. The prepared films were evaluated for their physicochemical properties such as weight variation, thickness, tensile strength, folding endurance, elongation (%), flatness, moisture content, moisture uptake, and the drug content uniformity. The films were also evaluated for the in vitro drug release and ex vivo drug permeation. The increasing ratios of Methocel?:Eudragit? polymers in the formulation linearly and significantly increased the moisture content, moisture uptake, water vapor transmission rate (WVTR), and the transdermal flux of GRN from the film formulations. Increasing levels of Methocel? in the formulations also increased the rate and extent of the GRN release and the GRN permeation from the prepared films. KEY WORDS film-forming polymers hydrophilic polymers permeation enhancers transdermal films